Calumet Specialty Products Partners Stock Price, News & Analysis (NASDAQ:CLMT)

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calumet Specialty Products Partners in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CLMT shares.
View CLMT analyst ratings or view top-rated stocks.

3 brokers have issued 1 year price targets for Calumet Specialty Products Partners' stock. Their CLMT share price targets range from $17.00 to $25.00. On average, they predict the company's stock price to reach $20.50 in the next year. This suggests a possible upside of 17.0% from the stock's current price.
View analysts price targets for CLMT or view top-rated stocks among Wall Street analysts.

Calumet Specialty Products Partners' stock was trading at $16.88 at the start of the year. Since then, CLMT stock has increased by 3.8% and is now trading at $17.52.
View the best growth stocks for 2023 here.

Calumet Specialty Products Partners saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 367,500 shares, an increase of 25.7% from the October 31st total of 292,400 shares. Based on an average daily trading volume, of 125,900 shares, the days-to-cover ratio is presently 2.9 days. Approximately 0.6% of the shares of the company are sold short.
View Calumet Specialty Products Partners' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 20th 2024.
View our CLMT earnings forecast.

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) posted its quarterly earnings data on Thursday, November, 9th. The oil and gas company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.13) by $0.16. The oil and gas company earned $1.15 billion during the quarter, compared to analyst estimates of $1.03 billion. Calumet Specialty Products Partners had a net margin of 1.01% and a negative trailing twelve-month return on equity of 4.22%.

18 employees have rated Calumet Specialty Products Partners Chief Executive Officer Tim Go on Glassdoor.com. Tim Go has an approval rating of 42% among the company's employees. This puts Tim Go in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Calumet Specialty Products Partners investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Summit Midstream Partners (SMLP), Viper Energy (VNOM), Washington Prime Group (WPG), Roper Technologies (ROP) and New Residential Investment (NRZ).

Calumet Specialty Products Partners' stock is owned by many different retail and institutional investors. Top institutional investors include F M Investments LLC (0.69%), Raymond James & Associates (0.41%), Royal Bank of Canada (0.39%), Barnett & Company Inc. (0.36%), Wolverine Trading LLC (0.00%) and Barclays PLC (0.25%). Insiders that own company stock include Daniel J Sajkowski, James S Carter, Louis Todd Borgmann, Ryan Willman, Scott Obermeier and Stephen P Mawer.
View institutional ownership trends.

Shares of CLMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.